Coffee drinking and risk of endometrial cancer - A population-based cohort study

International Journal of Cancer

Volumn 125, Issue 10, 2009, Pages 2413-2417

  Friberg, Emilie ^a   Orsini, Nicola ^a   Mantzoros, Christos S ^b   Wolk, Alicja ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Coffee; Diet; Endometrial cancer; Epidemiology; Prospective study

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; COFFEE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; COFFEE; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 70349850470     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24543     Document Type: Article

References (52)

1. Arnlov J, Vessby B, Riserus U. Coffee consumption and insulin sensitivity. JAMA 2004;291:1199-1201
2. van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005;294:97-104. (Pubitemid 41002844)
3. IARC. Weight control and physical activity. Lyon: IARC Press, 2002.
4. Modesitt SC, van Nagell JR, Jr. The impact of obesity on the incidence and treatment of gynecologic cancers: a review. Obstet Gynecol Surv 2005;60:683-692
5. Schouten LJ, Goldbohm RA, van den Brandt PA. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst 2004;96:1635-1638 (Pubitemid 39534888)
6. Friberg E, Mantzoros CS, Wolk A. Physical activity and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev 2006;15:2136-2140 (Pubitemid 44877037)
7. Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007;50: 1365-1374 (Pubitemid 46879010)
8. Shimazu T, Inoue M, Sasazuki S, Iwasaki M, Kurahashi N, Yamaji T, Tsugane S. Coffee consumption and risk of endometrial cancer: a prospective study in Japan. Int J Cancer 2008;123:2406-2410
9. Stensvold I, Jacobsen BK. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 1994;5: 401-408 (Pubitemid 24302703)
10. Koizumi T, Nakaya N, Okamura C, Sato Y, Shimazu T, Nagase S, Niikura H, Kuriyama S, Tase T, Ito K, Tsubono Y, Okamura K, et al. Case-control study of coffee consumption and the risk of endometrial endometrioid adenocarcinoma. Eur J Cancer Prev 2008;17:358-363
11. Petridou E, Koukoulomatis P, Dessypris N, Karalis D, Michalas S, Trichopoulos D. Why is endometrial cancer less common in Greece than in other European Union countries? Eur J Cancer Prev 2002;11: 427-432
12. Hirose K, Niwa Y, Wakai K, Matsuo K, Nakanishi T, Tajima K. Coffee consumption and the risk of endometrial cancer: evidence from a case-control study of female hormone-related cancers in Japan. Cancer Sci 2007;98:411-415 (Pubitemid 46195614)
13. McCann SE, Yeh M, Rodabaugh K, Moysich KB. Higher regular coffee and tea consumption is associated with reduced endometrial cancer risk. Int J Cancer 2009;124:1650-1653
14. Bravi F, Scotti L, Bosetti C, Zucchetto A, Talamini R, Montella M, Greggi S, Pelucchi C, Negri E, Franceschi S, La Vecchia C. Food groups and endometrial cancer risk: a case-control study from Italy. Am J Obstet Gynecol 2009;200:293e1-e7.
15. Terry P, Vainio H, Wolk A, Weiderpass E. Dietary factors in relation to endometrial cancer: a nationwide case-control study in Sweden. Nutr Cancer 2002;42:25-32. (Pubitemid 35007003)
16. Levi F, Franceschi S, Negri E, La Vecchia C. Dietary factors and the risk of endometrial cancer. Cancer 1993;71:3575-3581 (Pubitemid 23152668)
17. Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, Liu LQ, Kolonel LN. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 1997;57:5077-5085 (Pubitemid 27498123)
18. Coffeeresearch. Available at: http://www.coffeeresearch.org/market/ consumption.htm 2008.
19. Kuskowska-Wolk A, Bergstrom R, Bostrom G. Relationship between questionnaire data and medical records of height, weight and body mass index. Int J Obes Relat Metab Disord 1992;16:1-9.
20. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-313
21. Grambsch PM, Thernau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-526
22. Harrell FE, Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 1988;80:1198-1202
23. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-561 (Pubitemid 19116001)
24. Arion WJ, Canfield WK, Ramos FC, Schindler PW, Burger HJ, Hemmerle H, Schubert G, Below P, Herling AW. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys 1997;339:315-322 (Pubitemid 27199976)
25. Clifford MN. Chlorogenic acids and other cinnamates-nature, occurence, dietary burden, absorption and metabolism. J Sci Food Agric 2000;80:1033-1043
26. Johnston KL, Clifford MN, Morgan LM. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 2003; 78:728-733
27. Agardh EE, Carlsson S, Ahlbom A, Efendic S, Grill V, Hammar N, Hilding A, Ostenson CG. Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 2004;255:645-652 (Pubitemid 38703583)
28. Williams CJ, Fargnoli JL, Hwang JJ, van Dam RM, Blackburn GL, Hu FB, Mantzoros CS. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care 2008;31:504-507
29. Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, Gershenson DM, Lu KH. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 2006;106:2376-2381 (Pubitemid 43787661)
30. Dal Maso L, Augustin LS, Karalis A, Talamini R, Franceschi S, Trichopoulos D, Mantzoros CS, La Vecchia C. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 2004;89: 1160-1163 (Pubitemid 38368405)
31. Petridou E, Mantzoros C, Dessypris N, Koukoulomatis P, Addy C, Voulgaris Z, Chrousos G, Trichopoulos D. Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 2003;88:993-997 (Pubitemid 36337745)
32. Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Lukanova A, Rinaldi S, Dossus L, Slimani N, Lundin E, Tjonneland A, Olsen A, et al. Plasma adiponectin levels and endometrial cancer risk in preand postmenopausal women. J Clin Endocrinol Metab 2007;92:255-263 (Pubitemid 46067541)
33. Nagamani M, Stuart CA. Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture. Am J Obstet Gynecol 1998;179:6-12. (Pubitemid 28394466)
34. Kazer RR. Insulin resistance, insulin-like growth factor I and breast cancer: a hypothesis. Int J Cancer 1995;62:403-406
35. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991; 72:83-89
36. Irwin JC, de las Fuentes L, Dsupin BA, Giudice LC. Insulin-like growth factor regulation of human endometrial stromal cell function: coordinate effects on insulin-like growth factor binding protein-1, cell proliferation and prolactin secretion. Regul Pept 1993;48:165-177
37. Murphy LJ. Growth factors and steroid hormone action in endometrial cancer. J Steroid Biochem Mol Biol 1994;48:419-423
38. Corocleanu M. Hypothesis for endometrial carcinoma carcinogenesis. Preventive prospects. Clin Exp Obstet Gynecol 1993;20:254-258
39. Thiet MP, Osathanondh R, Yeh J. Localization and timing of appearance of insulin, insulin-like growth factor-I, and their receptors in the human fetal mullerian tract. Am J Obstet Gynecol 1994;170:152-156 (Pubitemid 24084048)
40. Ordener C, Cypriani B, Vuillermoz C, Adessi GL. Epidermal growth factor and insulin induce the proliferation of guinea pig endometrial stromal cells in serum-free culture, whereas estradiol and progesterone do not. Biol Reprod 1993;49:1032-1044 (Pubitemid 23313829)
41. Weiderpass E, Brismar K, Bellocco R, Vainio H, Kaaks R. Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk. Br J Cancer 2003;89:1697-1704 (Pubitemid 37464142)
42. London S, Willett W, Longcope C, McKinlay S. Alcohol and other dietary factors in relation to serum hormone concentrations in women at climacteric. Am J Clin Nutr 1991;53:166-171 (Pubitemid 21917626)
43. Ferrini RL, Barrett-Connor E. Caffeine intake and endogenous sex steroid levels in postmenopausal women. The Rancho Bernardo Study. Am J Epidemiol 1996;144:642-644 (Pubitemid 26322515)
44. Graham JD, Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev 1997;18:502-519
45. Mazur W. Phytoestrogen content in foods. Baillieres Clin Endocrinol Metab 1998;12:729-742
46. Horn-Ross PL, John EM, Canchola AJ, Stewart SL, Lee MM. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 2003;95:1158-1164 (Pubitemid 37045394)
47. Bandera EV, Williams MG, Sima C, Bayuga S, Pulick K, Wilcox H, Soslow R, Zauber AG, Olson SH. Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey. Cancer Causes Control 2009. [Epub ahead of print].
48. Svilaas A, Sakhi AK, Andersen LF, Svilaas T, Strom EC, Jacobs DR, Jr, Ose L, Blomhoff R. Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 2004;134:562-567 (Pubitemid 38298496)
49. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991;14:1132-1143
50. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54:254-260
51. Steffes MW, Gross MD, Schreiner PJ, Yu X, Hilner JE, Gingerich R, Jacobs DR, Jr. Serum adiponectin in young adults-interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. Ann Epidemiol 2004;14:492-498
52. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459-469 (Pubitemid 36577787)